SPECT-CT在早期口腔癌前哨淋巴结识别中的附加价值
该研究纳入66例早期(T1-T2)口腔癌且临床颈部阴性(cN0)的患者,在平面淋巴显像基础上加做SPECT-CT,回顾性分析其附加价值。两种成像方式联合的识别率为98%(65/66),SPECT-CT在14例患者(22%)中额外识别出15枚前哨淋巴结(SLN),其中2枚(13%)为唯一转移灶,导致3%(2/65)的患者分期上调。结论推荐在早期口腔癌前哨淋巴结活检中将SPECT-CT加入平面淋巴显像,以识别更多(阳性)SLN并为手术提供更好的拓扑定位。
要点
- SPECT-CT联合平面淋巴显像的SLN识别率为98%(65/66)。
- SPECT-CT在14例患者(22%)中额外识别15枚SLN,其中2枚(13%)为唯一转移灶。
- 在至少一枚阳性SLN的患者中,20%的唯一阳性SLN因加做SPECT-CT而被检出。
核心结论
- 推荐在早期口腔癌前哨淋巴结活检中,将SPECT-CT加入平面淋巴显像,以识别更多(阳性)SLN并为手术提供更好的拓扑定位。
研究设计与样本
- 对66例连续纳入的早期(T1-T2)口腔癌且临床颈部阴性(cN0)患者,在平面淋巴显像基础上加做SPECT-CT,由核医学医师、外科医师和研究者组成的团队进行回顾性分析。
主要发现
- 两种成像方式联合的识别率为98%(65/66)。
- SPECT-CT在14例患者(22%)中额外识别出15枚SLN,其中2/15(13%)为唯一转移灶,导致分期上调率为3%(2/65)。
- 在至少一枚阳性SLN的患者中,20%的唯一阳性SLN因加做SPECT-CT而被检出。
- SPECT-CT在2例患者(3%)中被认为提供了重要的解剖信息。
- 在5/65(8%)的患者中,平面淋巴显像 initially 判读为SLN的病灶在加做SPECT-CT后被判读为非SLN。
临床怎么用
- 作者推荐在早期口腔癌前哨淋巴结活检中,将SPECT-CT加入平面淋巴显像,以识别更多(阳性)SLN并为手术提供更好的拓扑定位。
局限性
- 本队列中有4例前哨淋巴结活检操作出现假阴性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the role of single-photon emission computed tomography with computed tomography (SPECT-CT) for the identification of sentinel lymph nodes (SLNs) in patients with early stage (T1-T2) oral cancer and a clinically negative neck (cN0). METHODS: In addition to planar lymphoscintigraphy, SPECT-CT was performed in 66 consecutive patients with early stage oral cancer and a clinically negative neck. The addition of SPECT-CT to planar images was retrospectively analyzed for the number of additional SLNs, more precise localization of SLNs, and importance of anatomical information by a team consisting of a nuclear physician, surgeon, and investigator. RESULTS: Identification rate for both imaging modalities combined was 98% (65/66). SPECT-CT identified 15 additional SLNs in 14 patients (22%). In 2/15 (13%) of these additional SLNs, the only metastasis was found, resulting in an upstaging rate of 3% (2/65). In 20% of the patients with at least one positive SLN, the only positive SLN was detected due to the addition of SPECT-CT. SPECT-CT was considered to add important anatomical information in two patients (3%). In 5/65 (8%) of the patients initially scored SLNs on planar lymphoscintigrams were scored as non-SLNs when SPECT-CT was added. There were four false-negative SLN biopsy procedures in this cohort. CONCLUSIONS: The addition of SPECT-CT to planar lymphoscintigraphy is recommended for the identification of more (positive) SLNs and better topographical orientation for surgery in sentinel lymph node biopsy for early stage oral cancer.
引用
- den Toom IJ, van Schie A, van Weert S, et al. The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer. Eur J Nucl Med Mol Imaging. 2017. PMID: 28132110. doi:10.1007/s00259-017-3613-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。